Table 1.
Peptides Selected for In vivo Imaging
Name | Sequence | Description | D/L | Results | Reference |
---|---|---|---|---|---|
none |
DWGKGGRWRLWPGASGKTEA and PGRSPFTGKKLFNQEFSQDQ |
Selected by phage display | L | Binds amyloid form of Aβ40, labels amyloid plaques in AD brains slices, discussed as carrier protein for plaque treatment and in vivo imaging | Kang et al., 2003 [40] |
D1/ ACI-80 | ACI-80: QSHYRHISPAQV | Selected by mirror image phage display | D | Aggregate specific, stains human Aβ plaques selectively, stains plaques in mice ex vivo | Wiesehan et al.,
2003 [46] Van Groen et al., 2009 [47] |
none |
C-IPLPFYN-C / C-FRHMTEQ-C |
Selected by phage display | L | Kd for Aβ42 in micromolar range, specific interaction with plaques on brain sections (immunochemistry), encouraging preliminary MRI in vivo study in mice after opening of bbb by mannitol | Larbanoix et al., 2008 [48] |
Pep1 Pep2 |
LIAIMA IFALMG |
Selected by phage display, library based on Aβ sequence | L | Kd for Aβ42 in micromolar range, specific interaction with plaques in human brain sections (immunochemistry), inhibit Aβ aggregation | Larbanoix et al., 2011 [49] |
bbb: blood brain barrier. D/L: describes peptide conformation.